FLIP(L) determines p53 induced life or death
Lees, A.; McIntyre, A. J.; Falcone, F.; Crawford, N. T.; McCann, C.; Quinn, G. P.; Roberts, J. Z.; Sessler, T.; Gallagher, P. F.; McAllister, K.; McLaughlin, K.; Allen, W. L.; Holohan, C.; Egan, L. J.; Ryan, A. E.; Labonte-Wilson, M.; Dunne, P. D.; Wappett, M.; Coyle, V. M.; Johnston, P.; Kerr, E. M.; Longley, D. B.; McDade, S. S.
Show abstract
How p53 differentially activates cell cycle arrest versus cell death remains poorly understood. Here, we demonstrate that upregulation of canonical pro-apoptotic p53 target genes in colon cancer cells imposes a critical dependence on the long splice form of the caspase-8 regulator FLIP (FLIP(L)), which we identify as a direct p53 transcriptional target. Inhibiting FLIP(L) expression with siRNA or Class-I HDAC inhibitors promotes apoptosis in response to p53 activation by the MDM2 inhibitor Nutlin-3A, which otherwise predominantly induces cell-cycle arrest. When FLIP(L) upregulation is inhibited, apoptosis is induced in response to p53 activation via a novel ligand-independent TRAIL-R2/caspase-8 complex, which, by activating BID, induces mitochondrial-mediated apoptosis. Notably, FLIP(L) depletion inhibits p53-induced expression of the cell cycle regulator p21 and enhances p53-mediated upregulation of PUMA, with the latter activating mitochondrial-mediated apoptosis in FLIP(L)-depleted, Nutlin-3A-treated cells lacking TRAIL-R2/caspase-8. Thus, we report two previously undescribed, novel FLIP(L)-dependent mechanisms that determine cell fate following p53 activation.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The Second Mitochondrial Activator of Caspases (SMAC) regulates growth, inflammation and mitochondrial integrity in cancer cells 95%
- Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3 94%
- CRISPR Screens Identify Novel Regulators of cFLIP Dependency and Ligand-Independent, TRAIL-R1-Mediated Cell Death 94%
Similar papers in this journal
- A phosphorylation of RIPK3 kinase initiates an intracellular apoptotic pathway that promotes corpus luteum regression 95%
- Inhibitors of ROCK kinases induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells 95%
- PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.